- EU | EMA Adds New RWD Q&A — Reinforcing ICH M14 Expectations for Non-Interventional Studies Using Real-World Data Gallery
EU | EMA Adds New RWD Q&A — Reinforcing ICH M14 Expectations for Non-Interventional Studies Using Real-World Data
2026, EMA, EU, May 2026, Members-Only, Moderate Update, RWD to Support Reg Decisions, Secondary Use of Existing Data
EU | EMA Adds New RWD Q&A — Reinforcing ICH M14 Expectations for Non-Interventional Studies Using Real-World Data
Please login to view this page.
EU | AI Act Implementation Timelines Refocus Urgency for AI-Enabled Real-World Research
Please login to view this page.
- CHINA | NEW BIOMEDICAL TECHNOLOGIES REGULATION TAKES EFFECT — CREATING A NATIONAL FRAMEWORK FOR CLINICAL RESEARCH, TRANSLATIONAL APPLICATION AND LONG-TERM SAFETY OVERSIGHT Gallery
CHINA | NEW BIOMEDICAL TECHNOLOGIES REGULATION TAKES EFFECT — CREATING A NATIONAL FRAMEWORK FOR CLINICAL RESEARCH, TRANSLATIONAL APPLICATION AND LONG-TERM SAFETY OVERSIGHT
CHINA | NEW BIOMEDICAL TECHNOLOGIES REGULATION TAKES EFFECT — CREATING A NATIONAL FRAMEWORK FOR CLINICAL RESEARCH, TRANSLATIONAL APPLICATION AND LONG-TERM SAFETY OVERSIGHT
Please login to view this page.
- BRAZIL | INAEP Issues New Operational Guidance to Implement Law No. 14,874/2024 — Strengthening CEP Governance, Review Timelines and SINEP Standardisation Gallery
BRAZIL | INAEP Issues New Operational Guidance to Implement Law No. 14,874/2024 — Strengthening CEP Governance, Review Timelines and SINEP Standardisation
BRAZIL | INAEP Issues New Operational Guidance to Implement Law No. 14,874/2024 — Strengthening CEP Governance, Review Timelines and SINEP Standardisation
Please login to view this page.
EU | TEHDAS2 Launches New Public Consultations to Support Implementation of the European Health Data Space
Please login to view this page.
US | FDA Advances Digital Pharmacovigilance Modernisation Through New Electronic ICSR Rule and AEMS Public Dashboard
Please login to view this page.
- Singapore | HSA Updates Post-Marketing Vigilance Requirements for Therapeutic Products and CTGTPs — Expanding Lifecycle Pharmacovigilance and Safety Reporting Expectations Gallery
Singapore | HSA Updates Post-Marketing Vigilance Requirements for Therapeutic Products and CTGTPs — Expanding Lifecycle Pharmacovigilance and Safety Reporting Expectations
Singapore | HSA Updates Post-Marketing Vigilance Requirements for Therapeutic Products and CTGTPs — Expanding Lifecycle Pharmacovigilance and Safety Reporting Expectations
Please login to view this page.
Canada | Health Canada Expands Lifecycle Oversight of Medical Devices Through New Guidance Framework
Please login to view this page.
Brazil | Major Reform of National Research Ethics Oversight Advances Through New INAEP Governance Framework and Regulatory Actions
Please login to view this page.










